Leadership Vacuum: Agencies in New York and Beyond Pass the Buck on Opioid Cash Oversight

Companies accused of recklessly marketing and distributing prescription opioid painkillers are paying roughly $58 billion to settle lawsuits over their role in fueling the addiction crisis. It’s a pot of gold eyed by addiction treatment providers, companies creating the latest opioid-related products, and government officials struggling to balance budgets. Nearly half of that money is…

Read More

The Drug Changing Medicine

By EMANUEL SARKEES The United States is in the middle of what researchers are calling one of the most significant pharmacological developments in modern medicine. GLP-1 receptor agonists, the drug class behind Ozempic and Wegovy, have become able to reduce obesity, lower cardiovascular risk, control blood sugar, and show signals improving areas like addiction and…

Read More

Insurers Hedge on Trump-Backed Pledge To Improve Denials Process

One year after the Trump administration announced that dozens of health insurers had signed a six-part pledge promising to reduce barriers to doctor-recommended care, some insurers now say they won’t implement all the promised initiatives. Meanwhile, patients, their advocates, and clinicians say little has improved. “It has never been this bad for patients,” said U.S….

Read More